A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics

Jacinda C. Abdul-Mutakabbir, Elizabeth B. Hirsch, Caroline Ko, Britny R. Brown, Aiman Bandali, Jason Mordino, Leah H. Yoke, Taison Bell, Talia H. Swartz, Uzma Syed, Matifadza Hlatshwayo, Ila M. Saunders

Research output: Contribution to journalComment/debatepeer-review

6 Scopus citations
Original languageEnglish (US)
Article number100263
JournalThe Lancet Regional Health - Americas
Volume11
DOIs
StatePublished - Jul 2022

Bibliographical note

Funding Information:
JAM has received advisory board honoraria from Shionogi. EBH has received grant funding from Merck outside of the discussed topic, and advisory board honoraria from Merck, MeMed, and Melinta. US is a board member of the IDSA IDA&E Committee and Eid Holiday Coalition, and founder and CEO of Align Us inc. IMS has received advisory board honoraria from EUSA Pharma and serves on the Horizon CME Committee as a member and speaker. All other authors declare no relevant conflicts of interest or financial relationships.

Cite this